Co-Diagnostics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $162 | $50 | $149 | $641 |
Gross Profit | 130 | 28 | -105 | 343 |
EBITDA | -7,766 | -7,240 | -11,549 | -9,883 |
EBIT | -8,057 | -7,521 | -11,907 | -10,234 |
Net Income | -7,730 | -7,533 | -11,031 | -9,696 |
Net Change In Cash | 162 | 50 | 149 | 641 |
Free Cash Flow | -8,688 | -8,837 | -8,303 | -7,403 |
Cash | 11,115 | 1,903 | 2,936 | 10,797 |
Basic Shares | 33,108 | 32,048 | 33,053 | 30,494 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $3,915 | $6,812 | $34,218 | $97,885 |
Gross Profit | 2,916 | 2,627 | 28,737 | 86,310 |
EBITDA | -38,704 | -41,475 | -10,308 | 46,400 |
EBIT | -40,081 | -42,706 | -11,621 | 46,064 |
Net Income | -37,639 | -35,332 | -14,238 | 36,658 |
Net Change In Cash | 3,915 | 6,812 | 34,218 | 97,885 |
Cost of Revenue | -65,633 | 45,630 | ||
Free Cash Flow | -29,903 | -23,447 | 5,141 | 40,411 |
Cash | 2,936 | 14,916 | 22,973 | 88,607 |
Basic Shares | 30,335 | 29,346 | 31,479 | 29,903 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.23 |
2025-03-31 | -$0.25 |
2024-12-31 | -$0.37 |
